About Sarah Hassan
Sarah Hassan is a director at Vinci Pharmaceuticals.
Form D filings also name Sarah Hassan as a director at PleoPharma.
Experience
This experience comes from Sarah Hassan's profile and from SEC filings. For roles taken from filings, the years are when the filings name Sarah Hassan in the role, so the role may have started earlier or lasted longer.
MI
Myosin Therapeutics Inc. Current
Board Member
2025 – Present
Pleopharma, Inc. Current
Director
2022 – Present · Phoenixville, PA
Develops a drug for adults experiencing cannabis withdrawal.
WE
Welmedix Current
Owner Operator
2022 – Present
DC
Dynagrow Capital Current
Managing Partner
2010 – Present
CV
Caerus Ventures
Partner
2014 – 2024
IH
IM HealthScience
CFO
2010 – 2021
Key Colleagues at Startups
The people Sarah Hassan works with at each company, as listed on that company's latest Form D.
Pleopharma, Inc. · Form D, Aug 10, 2026
KT
Kyle Tomlin
Director
GC
Ginger Constantine
Executive officer and director
JC
Jay Constantine
Chief Medical Officer, Co-Founder and Director
MT
McInerney Timothy
Director
TP
Thomas Poche
Executive officer
DC
Daniel Cartwright
Chief Financial Officer
RF
Robert Finizio
Executive Director
PB
Paul Bisaro
Director
TT
Tommy Thompson
Director
KM
Kyle Mowitz
Director
BS
Brij Sharma
Director
Vinci Pharmaceuticals, Inc. · Form D, Jan 26, 2026
RL
Richard Lindstrom
Director
SK
Sigurd Kirk
Director
NJ
Neil Austrian Jr.
Director
PG
Philip Gioia
Chief Executive Officer and director